Search results
HDFC Bank's share price plunges over 4% after weak Q1FY25 numbers
Business Standard India· 2 days agoHDFC Bank shares plunged 4.55 per cent on Friday to close at Rs 1,648.10 on the BSE, after the bank...
Emcure Pharma IPO receives strong response, subscribed 67.86 times on third bidding day; Issue...
Livemint· 2 days agoAccording to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals...
'Large-cap' and 'mid-cap' threshold up 25% amid stock market rally
Business Standard India· 2 days agoMarket capitalization rules: The threshold has jumped from Rs 67,000 crore and Rs 22,000 crore after...
Sensex, Nifty log fifth straight weekly advance; HDFC Bank down 4.6%
Business Standard India· 2 days agoThe losses in HDFC Bank came after the private sector lender reported a sequential decline in loans...
India’s mutual fund industry nearly twice the size of Pakistan’s GDP
Financial Express· 2 days agoThe Indian mutual fund industry has grown by leaps and bounds over the past decade. With assets...
Sebi issues guidelines to streamline operations of credit rating agencies
Business Standard India· 2 days agoMarkets regulator Sebi has issued new guidelines to streamline operations and enhance the ease of...
What led to the underperformance of Mirae Asset Large Cap Fund - CNBC TV18
CNBC TV18· 2 days agoMirae Asset Large Cap Fund, once a top performer, has recently lagged behind its peers and...
Moneycontrol Pro Panorama | The peak of reckoning
CNBC Awaaz· 2 days agoWhen Ed Hillary and Tenzing Norgay reached Mount Everest’s peak in 1953, only one or two expeditions per year were allowed. Today, a multi-billion-dollar...
Restaurants Brand Asia stock rallies 5% after HDFC Mutual Fund buys stake
Business Standard India· 2 days agoShares of Restaurants Brand Asia soared up to 5 per cent at 113.92 per share on the BSE in Friday's...
Shilpa Medicare share price jumps 17% on positive clinical results for a kidney disease drug. Should...
Livemint· 2 days agoShilpa Medicare share price on Friday's trading session surged 17% to hit a 52-week high following the release of encouraging results from a key clinical study of oxylanthanum carbonate by Unicyctive ...